The 29 September 2022 saw the nineteenth virtual Revolutionizing Healthcare engagement sessions of the van der Schaar Lab and its audience of practising clinicians.
That session was specifically focussed on using machine learning to tackle Cystic Fibrosis.
At the beginning of the session, Andreas Floto and Mihaela van der Schaar offered introductory presentations describing the challenges clinicians are currently facing in regards to cystic fibrosis, and showing examples of current developments in the field of ML tackling these problems.
The latter part of the session featured an engaging roundtable comprising an expert panel of specialists in the area of cystic fibrosis:
– Prof Damian Downey, MD (Clinical Professor at the School of Medicine, Dentistry, and Biomedical Science at Queen’s University Belfast; Honorary Consultant in Respiratory Medicine at the Belfast Health and Social Care Trust)
– Dr Jamie Duckers, MD (Consultant Respiratory Physician, Research Lead for the All Wales Adult CF service, and Rare Diseases lead for NHS Wales)
– Dr Robert Gray, MD (Senior Clinical Fellow and Honorary Consultant Physician at the University of Edinburgh)
– Dr Charles Haworth, MD FRCP (Consultant Physician, Cambridge Centre for Lung Infection at Royal Papworth Hospital; Honorary Visiting Senior Fellow, Department of Medicine at the University of Cambridge)
– Prof Alexander Horsley, MD (Professor of Respiratory Medicine at the University of Manchester, and Consultant at Manchester Adult Cystic Fibrosis Centre)
– Caroline Cartellieri Karlsen, MBA (Trustee at Asthma + Lung UK; Non-Executive Director at Europ Assistance and the Museum of London Trading Board; former Trustee at Cystic Fibrosis Trust; former Governor at Royal Brompton and Harefield NHS Foundation Trust)
Our panelists answered a number of questions posed by Mihaela and the audience.
If you didn’t manage to join us last week, we’d strongly recommend watching the archived video, which is now available on YouTube:
NOTE: This information was up-to-date at the time of the presentation but does not take into account material published since then.
If you are interested in learning more about the topic, please have a look at our page on next-generation cystic fibrosis.
Sign up for our upcoming sessions here.